Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma.
Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Matthew K
MK
Stein
Bryant B
BB
Summers
Christine A
CA
Wong
Hilary L
HL
Box
Kerry O
KO
Cleveland
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005134:Eye Neoplasms / Q000473:pathology; D006801:Humans; D000074324:Ipilimumab; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000628:therapy; D008582:Meningitis, Aseptic / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D008590:Meningoencephalitis / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D000074324:Ipilimumab